Akums Drugs & Pharmaceuticals Ltd

NSE: AKUMS · BSE: 544222 · Pharmaceuticals & Biotechnology · 35 announcements

Share price: ₹826.50
Market cap: ₹13,009 Cr
Revenue (annual): ₹4,359 Cr
Net profit (annual): ₹255.2 Cr
P/E (TTM): 44.6×Sector 47.4×
Promoter holding: 75.26%+0.00% QoQ
FII holding: 1.91%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 7 Earnings Call 5 Legal & Regulatory 4 Financial Results 4 Adverse Business Impact 3 Results Update 2 Management Change 2 Board Meeting Date 2 Merger & Restructuring 1 Fund Raise 1 Credit Rating 1 Capacity Expansion 1 Board Meeting Outcome 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

8 Aug 2026 17:01 IST NSE

Results Update

Akums Drugs & Pharmaceuticals Results Update

Akums Drugs reported Q1 FY27 consolidated revenue of ₹1,167 crore, reflecting 13.9% year-on-year growth. PAT rose to ₹101 crore compared to ₹65 crore in Q1 FY26.

Read the filing ↗

14 May 2026 16:32 IST NSE

Results Update

Akums Drugs & Pharmaceuticals Results Update

Akums Drugs reported ₹1,158 Crore Q4 revenue, marking 9.7% growth. Strong performance in CDMO business drove significant margin improvement and profitability for FY26.

Value: ₹1,158 Cr

Read the filing ↗